CLASS II ONGOING Device recall · Reported 24 Dec 2025 · FDA Enforcement Report
Xpert¿ Bcr-abl Ultra recalled by Cepheid
Cepheid is recalling Xpert¿ Bcr-abl Ultra, distributed in 27 states. The recall was initiated on 30 Oct 2025 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-0959-2026
- FDA event ID
- 98004
- Recalling firm
- Cepheid, Sunnyvale, CA
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 30 Oct 2025
- FDA classified
- 18 Dec 2025
- Reported
- 24 Dec 2025
- Type
- Voluntary: Firm initiated
- Reason category
- Labeling Errors
- Device type
- Other Medical Devices
Timeline
| 30 Oct 2025 | Recall initiated by company | |
| 18 Dec 2025 | Classified by FDA | +49 days |
| 24 Dec 2025 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
Product as listed by the FDA
Brand Name: Xpert¿ BCR-ABL Ultra Model/Catalog Number: GXBCRABL-US-10
Where it was distributed
US: AL AR AZ CA CO FL GA IA IL KS KY LA MD ME MI MN MO NC NE NH NJ NY OH PA RI TX VA WA WI OUS: Algeria Armenia Australia Austria Bahrain Bangladesh Belgium Brazil Burkina Faso Cambodia Canada Canary islands Chile Colombia Cyprus Czech Republic Dem. Rep. Congo Djibouti Dominican Rep. Ecuador El Salvador Eswatini Finland France Frenc.Polynesia Gambia Georgia Germany Ghana Greece Guadeloupe Guatemala Honduras Hong Kong India Indonesia Iraq Israel Italy Jamaica Jordan Kazakhstan Kenya Kuwait Latvia Lebanon Lithuania Luxembourg Malawi Malaysia Mauritania Mauritius Mexico Morocco Mozambique Myanmar Netherlands New Caledonia New Zealand Nicaragua Norway Oman Pap. New Guinea Peru Philippines Poland Portugal Qatar Rep.of Congo Reunion Rwanda Saudi Arabia Senegal Seychelles Singapore South Africa Spain Sri Lanka Sweden Switzerland Taiwan Tajikistan Tanzania Thailand Togo Tunisia Uganda United Kingdom Uruguay Utd.Arab Emir. Venezuela Zambia Zimbabwe
AlabamaArkansasArizonaCaliforniaColoradoFloridaGeorgiaIowaIllinoisKansasKentuckyLouisianaMarylandMichiganMinnesotaMissouriNorth CarolinaNebraskaNew HampshireNew Jersey
Questions about this recall
Why was it recalled?
Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
Which lots are affected?
UDI: 07332940007102/ Lot Numbers: 1001456698, 1001463946, 1001472599, 1001477457, 1001480637, 1001483326, 1001500425
Where was it sold?
US: AL AR AZ CA CO FL GA IA IL KS KY LA MD ME MI MN MO NC NE NH NJ NY OH PA RI TX VA WA WI OUS: Algeria Armenia Australia Austria Bahrain Bangladesh Belgium Brazil Burkina Faso Cambodia Canada Canary islands Chile Colombia Cyprus Czech Republic Dem. Rep. Congo Djibouti Dominican Rep. Ecuador El Salvador Eswatini Finland France Frenc.Polynesia Gambia Georgia Germany Ghana Greece Guadeloupe Guatemala Honduras Hong Kong India Indonesia Iraq Israel Italy Jamaica Jordan Kazakhstan Kenya Kuwait Latvia Lebanon Lithuania Luxembourg Malawi Malaysia Mauritania Mauritius Mexico Morocco Mozambique Myanmar Netherlands New Caledonia New Zealand Nicaragua Norway Oman Pap. New Guinea Peru Philippines Poland Portugal Qatar Rep.of Congo Reunion Rwanda Saudi Arabia Senegal Seychelles Singapore South Africa Spain Sri Lanka Sweden Switzerland Taiwan Tajikistan Tanzania Thailand Togo Tunisia Uganda United Kingdom Uruguay Utd.Arab Emir. Venezuela Zambia Zimbabwe
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 98004This product is part of a recall event; the main page for the event is Xpert¿ Bcr-abl Ultra recalled by Cepheid.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Xpert¿ Bcr-abl Ultra recalled by Cepheid | Cepheid | Labeling Errors | 27 states |
More recalls from Cepheid
All 12| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Xpert¿ Bcr-abl Ultra recalled by Cepheid | Cepheid | Labeling Errors | 27 states |
| Device | CLASS II | Xpert MTB/RIF recalled by Cepheid | Cepheid | Potency & Assay | Nationwide |
| Device | CLASS II | Xpert SA Nasal Complete recalled by Cepheid | Cepheid | Potency & Assay | Nationwide |
| Device | CLASS II | Sample Collection Device, Part recalled by Cepheid | Cepheid | Packaging Defects | Nationwide |
| Device | CLASS II | Xpert Xpress Strep A, Xprstrepa recalled by Cepheid | Cepheid | Packaging Defects | Nationwide |
Other Other Medical Devices recalls
All 13,969| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | ANNOUNCED | Beds, Rails, Mattresses, and accessories recalled by MedlineMedline | Medline | Other | |
| Device | CLASS II | Philips Azurion 3 M15 recalled by Philips Medical Systems Nederl | Philips Medical Systems Nederl | Other | Nationwide |
| Device | CLASS II | Orthoscan Versa Accessory Cart recalled by Ziehm-orthoscan | Ziehm-orthoscan | Device Malfunction | Nationwide |
| Device | CLASS II | Philips Azurion 7 B12 recalled by Philips Medical Systems Nederl | Philips Medical Systems Nederl | Other | Nationwide |
| Device | CLASS II | Philips Azurion 7 M20 recalled by Philips Medical Systems Nederl | Philips Medical Systems Nederl | Other | Nationwide |